Header cover image

Hong Kong (HSI) Life Sciences Industry Analysis

UpdatedMar 21, 2023
DataAggregated Company Financials
  • 7D-8.6%
  • 3M-10.3%
  • 1Y-21.0%
  • YTD-28.0%

Over the last 7 days, the Life Sciences industry has dropped 6.3%, driven by WuXi Biologics (Cayman) declining 7.7%. Overall the industry is down 13% in 12 months. Looking forward, earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Hong Kong Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 21 Mar 2023HK$238.6bHK$26.4bHK$2.1b22.9x115.6x9x
Thu, 16 Feb 2023HK$313.3bHK$26.5bHK$2.1b25.1x149.5x11.8x
Sat, 14 Jan 2023HK$378.5bHK$26.7bHK$2.2b27.6x174.2x14.2x
Mon, 12 Dec 2022HK$288.2bHK$26.0bHK$2.0b27.9x144.4x11.1x
Wed, 09 Nov 2022HK$255.7bHK$25.6bHK$1.9b24.8x137.4x10x
Fri, 07 Oct 2022HK$256.4bHK$25.7bHK$1.9b20.5x134.5x10x
Sun, 04 Sep 2022HK$343.4bHK$26.3bHK$2.1b27.3x167.1x13x
Tue, 02 Aug 2022HK$384.6bHK$22.3bHK$2.1b12x187.6x17.2x
Thu, 30 Jun 2022HK$379.0bHK$22.4bHK$2.1b15.6x182.6x16.9x
Sat, 28 May 2022HK$284.4bHK$22.3bHK$2.1b13.1x138.4x12.7x
Mon, 25 Apr 2022HK$296.8bHK$22.9bHK$2.2b14.3x133.1x12.9x
Wed, 23 Mar 2022HK$314.7bHK$19.2bHK$1.5b21.1x205.9x16.4x
Fri, 18 Feb 2022HK$350.8bHK$18.7bHK$2.8b24.4x124.3x18.7x
Sun, 16 Jan 2022HK$477.6bHK$18.7bHK$2.8b29.6x170.2x25.6x
Tue, 14 Dec 2021HK$528.1bHK$18.7bHK$2.8b37.1x188.6x28.3x
Thu, 11 Nov 2021HK$536.7bHK$18.6bHK$2.8b35.4x192.2x28.9x
Sat, 09 Oct 2021HK$572.2bHK$18.5bHK$2.8b51.7x207.6x31x
Mon, 06 Sep 2021HK$628.0bHK$18.4bHK$2.7b52.9x228.9x34.1x
Wed, 04 Aug 2021HK$679.8bHK$18.4bHK$2.7b56x247.8x37x
Sat, 08 May 2021HK$524.9bHK$15.7bHK$1.4b47.5x363.3x33.5x
Tue, 09 Feb 2021HK$494.9bHK$13.1bHK$201.6m81.8x2455.4x37.7x
Mon, 02 Nov 2020HK$338.5bHK$11.4bHK$4.7m59.6x72765x29.8x
Thu, 06 Aug 2020HK$276.8bHK$9.7b-HK$169,775,475.5195.6x-1630.6x28.6x
Sun, 10 May 2020HK$201.1bHK$9.2bHK$329.6m91.1x610x21.7x
Price to Earnings Ratio


Total Market Cap: HK$170.2bTotal Earnings: HK$329.6mTotal Revenue: HK$9.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Life Sciences Industry Price to Earnings3Y Average 6333x202120222023
Current Industry PE
  • Investors are pessimistic on the Hong Kong Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 123x which is lower than its 3-year average PE of 6kx.
  • The 3-year average PS ratio of 24.0x is higher than the industry's current PS ratio of 9.6x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 84% per year over the last three years.
  • Revenues for these companies have grown 42% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare industry?

HK Market-1.82%
Life Sciences-8.59%
Clinical Research and Equipment-8.59%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1521 Frontage HoldingsHK$2.296.5%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.